Scopus BioPharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-8.7	-11.61	-27.73	-11.57	-2.69	-0.69
Depreciation & Amortization	0	0	0	0	0	0
Share-Based Compensation	0.32	0.35	0.67	0.29	0.21	0
Other Operating Activities	5.33	3.13	15.63	8.75	0.36	-0.06
Operating Cash Flow	-3.04	-8.13	-11.42	-2.53	-2.12	-0.75
Capital Expenditures	-1.55	-0	-0	0	-0	0
Investing Cash Flow	-1.55	-0	-0	0	-0	0
Common Stock Issued	1.97	0	20.1	3.27	1.78	0.54
Other Financing Activities	0.24	0.24	-2.54	1.08	0.41	0.06
Financing Cash Flow	2.22	0.24	17.56	4.35	2.18	0.6
Net Cash Flow	-0.79	-7.82	6.11	1.8	0.04	-0.16
Free Cash Flow	-4.59	-8.13	-11.43	-2.53	-2.12	-0.75
Free Cash Flow Per Share	-0.12	-0.39	-0.66	-0.19	-0.14	-0.05

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.